Selecta Biosciences, Inc.

Joint Bookrunner (CMPO)

Financial Advisor to Neuronetics on its Merger with Greenbrook TMS

Advisor to UCB on the Sale of the Rights of Nootropil® and Atarax® Products to Advanz Pharma